Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fresenius Medical Care ( (FMS) ) has issued an announcement.
Fresenius Medical Care AG released its interim financial report for the three and nine months ended September 30, 2025. The company has restructured its operations by introducing a new Value-Based Care segment as of June 1, 2025, to enhance its focus on value-based kidney care. This strategic move is expected to improve the company’s market positioning by aligning its internal management reporting with recent changes. The report highlights the company’s financial condition and results of operations, providing insights into its performance and strategic direction.
The most recent analyst rating on (FMS) stock is a Sell with a $22.00 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.
Spark’s Take on FMS Stock
According to Spark, TipRanks’ AI Analyst, FMS is a Outperform.
Fresenius Medical Care’s overall stock score is driven by strong earnings call performance and stable financial health. While the company shows robust revenue and cash flow growth, challenges like high debt reliance and external cost pressures temper the outlook. Technical indicators suggest a neutral market sentiment, and valuation metrics are reasonable but not exceptional.
To see Spark’s full report on FMS stock, click here.
More about Fresenius Medical Care
Fresenius Medical Care AG is a healthcare company based in Germany, primarily engaged in the distribution of healthcare products and equipment through its Care Enablement segment, and providing services for the treatment of chronic kidney disease and end-stage renal disease through its Care Delivery segment. The company also focuses on value-based kidney care through its newly created Value-Based Care segment.
Average Trading Volume: 328,062
Technical Sentiment Signal: Buy
Current Market Cap: $15.27B
For detailed information about FMS stock, go to TipRanks’ Stock Analysis page.